Cattle are the backbone of household economy in rural areas of India and many of them die after bites by potentially rabid dogs, despite being given currently recommended five shots of intramuscular (IM) rabies vaccination as Post Exposure Prophylaxis (PEP). In 2016, seven of 21 bovine bitten by rabid dogs given IM rabies vaccination died due to rabies in Shimla Municipality. This scenario prompted the authors to look for a suitable protocol, based on human studies, to save animals. We tested various schedules of IDRV in bovine and found that a schedule of 0.2 ml given in middle 1/3 rd of neck on day 0, 3, 7, 14 and 28 along with local wound infiltration of eRIG is sufficiently immunogenic and life saving in all of them, even if bitten by lab confirmed rabid dogs/mongoose as tested by CRI. Rabivac Vet, a Cell Culture Rabies Vaccine, available as 1 ml per vial was used off level for IDRV. While injecting the vaccine, a raised papule of ≥1 cm will appear slowly causing a peau d'orange appearance. All 60 bovine serum samples tested by RFFIT after IDRV, had titers more than 0.5 IU/ml on day 14. Thereafter, a total of 150 animals were given five doses of IDRV as PEP, with or without RIG, after their exposure to clinically or lab confirmed rabid dogs/mongoose and all sur- vived for more than a year. Serum samples from 15 animals bitten by lab confirmed rabid dogs/mongoose were collected on day 14 and tested for RVNA by RFFIT from NIMHANS Bangalore and all had desired antibody titers above 0.5 IU/ml, without any immunosuppression. The RFFIT titers in 55% bovine in all groups were more than adequate after one year and 100% of them had anamnestic response to a single 0.2 ml booster given at one year. Few of the bovine and even one equine (Horse. Figure 4) brought for PEP at some of nearby vet hospitals were given IM rabies vaccine with local eRIG infiltration also survived. Local eRIG infiltration appeared to have covered the lacuna of longer window period required for indigenous antibodies production through IM route in bovine that are not sufficiently produced by day 14. While five times less vaccine was used in this low cost protocol and the survival was 100% compared to traditional IM protocol where survival was 66%. Pre-exposure prophylaxis was found to be effective as 0.2 ml dose of IDRV on day 0, 3, 7 and all bovine had titers higher than the desired by day seven after single 0.2 ml vaccine booster at one year. Our study points towards a possibility of having short schedules of three shots IDRV vaccination in bovine with or without local RIG (depending on presence or absence of wound/s) as PEP and single shot IDRV as PrEP, but further studies are required on a large number of animals. Our study also points out for allowing intra-dermal use in animals as well and labeling vaccines for the same as this is low cost more immunogenic and less painful compare to IM administration.
Introduction
The exposure of domestic farm animals like cattle, buffaloes, horses, goats and sheep to bites of rabid dogs is of great socio-economic concern especially in rural areas where the cattle are the backbone of family economy and a dependable livelihood. In Shimla Municipality in 2016, seven of 21 jersey cows died due to clinical rabies despite having been given post-exposure prophylaxis (PEP) with recommended IM injections of rabies vaccine on day 0, 3, 7, 14 and 28. One of the adult cows died after 20 th day of exposure and another after 35 th day of exposure.
This may have occurred due to a short incubation period consequent to bite wounds mostly near brain (on head and neck region) or non-administration of rabies immunoglobulin (RIG) into wounds or failure of IM vaccination to induce early protective response. IM rabies vaccine in animals has shown protective effect [1] but still PEP failures in cattle have been reported from all parts of the Globe [2] . Even vaccine antigen titers when raised to 4.0 IU or even higher resulted in failure [3] underlining the inappropriateness of rabies vaccine alone in animal post exposure prophylaxis. [5] . IDRV rabies vaccination has proved to be more immunogenic than IM administration but IDRV protocols have not been formulated till date and no studies are there with IDRV Protocols tested on lab confirmed rabid dog bitten cattle; hence this study was undertaken. The efficacy of IDRV is well documented and practiced in human PEP in many countries including India and in our state of Himachal Pradesh [6] . Since the rabies immunoglobulins given based on body weight in animals have proven their efficacy in saving the life of animals like Sheep [7] (26 IU per Kg on the day of infection),
they cannot be practiced in larger animals as the costs are overwhelming. Human rabies immunoglobulins (HRIG), as tried in sheep are @ $100 per 2 ml vial.
A recent study by Bharti and Madhusudana et al. has shown that local infiltration of rabies immunoglobulins (RIGs) in and around wounds [8] is effective in preventing rabies even in lab confirmed rabid dog bite human patients and prompted us to do this study in animals to save their lives.
Methods
24 of the 60 healthy bovine without any known exposure to rabid animals, were randomly allocated to various groups (Table 1) by draw of lots and were given and Exp Dec 2017, was used. Equine rabies immunoglobulin (eRIG) procured from CRI Kasauli HP, India, having potency of 550 IU/ml was used.
Procedure/Technique of Intra-Dermal Vaccination
This involves injection of 0. 
Collection of Samples Post-Vaccination

Rapid Fluorescent Focus Inhibition Test (RFFIT)
RFFIT for estimation of rabies virus neutralizing antibodies (RVNA) was performed at the department of Neurovirology, NIMHANS using a WHO recom- 
Safety Assessment
The adverse events (both local & systemic) were recorded by observing the subjects for about 60 minutes after administration of vaccine and eRIG. Adverse events were evaluated using 4-point scale. 0-None; 1-Mild (an adverse event which has no effect on normal daily activities); 2-Moderate (an adverse event which interfere with normal daily activities); 3-Severe (an adverse event which prevent daily activities).
Inclusion and Exclusion Criteria
1) Inclusion criteria: Animals reporting within 72 hours of bite, aged 4 months to 15 years, owner willing to consent and animal available for one year to follow.
2) Exclusion criteria: Reluctant owner, animal has received rabies vaccine or RIG in past, Pregnancy or animal having helminth infection or malnutrition. 
Animal Subject Protection
Three Phases of the Study Protocol
Phase I: We took 24 domestic bovine out of 60 recruited, in first phase for varied schedule of vaccination to arrive at a suitable pre exposure and post exposure protocols through intradermal route. The animals were randomized into five groups, as follow:
• Group 1: Rabivac vaccine ID was given intradermal 0.2 ml in middle 1/3 rd of neck on day 0. Group II was given Rabivac on day 0, 3, Group III on day 0, 3, 7; Group IV: on day 0, 3, 7, 14 and Group V on day 0, 3, 7, 14, 28. Details are at Table 1 .
• RFFIT titers were measured at day 0, 14, 35, 90 and 365 to develop appropriate pre and post exposure prophylaxis (PEP) protocol.
Phase II: 150 bovine, bitten by lab confirmed rabid dogs or mongoose or clinically conformed rabid dogs, were given PEP based on PEP protocol developed in Phase I after RFFIT evaluation and animals followed for more than one year to observe the survival rate. Details are at Table 2 .
Phase III: To develop a pre exposure protocol (PrEP) in Bovines a booster of single 0.2 ml ID to a sub-group of available bovine was given on days 365 and RFFIT titers tested seen again tested on day 7. Details are at Table 3.
Results and Discussion
Phase I: Out of 60 animals recruited for study protocol, 25 animals, 41.7% (17 cows and 8 buffalos), were having natural antibody titers without vaccination above 0.5 IU/ml in the range of 0.9 IU/ml -15 IU/ml. Some of these animals were subsequently observed as to how they respond to regular course of antirabies vaccination compare to those having titres below 0.5 IU/ml on day zero.
While we observed that the response in all 5 groups to ID vaccine was robust on day 14 (Group 1 -5) given 0.2 ml vaccine ID on days 0, 3, 7, 14 and 28. Only one animal could reach the desired titers (>0.5 IU/ml) on day 14 in IM group which is considered adequate. As per WHO guidelines, a minimum level of 0.5 IU/mL is used as a correlate of protection. In healthy vaccinees, this level should be achieved by day 14 of a post-exposure immunization regimen, with or without simultaneous administration of RIG and irrespective of age [10] . Test of Significance: GMTs ID Vs IM is: 5.26 vs 0.38 (p = 0.0136), IM vaccine had significantly low titers than IDRV on day 14 which can be life threatening in cases of wounds on head and neck and may have contributed to observed vaccine failures IM.
To understand this strange phenomenon of existence of natural antibodies without vaccination mentioned above, we took serum samples from 12 cows 150 bovine bitten by suspected or laboratory confirmed rabid dogs were included in Phase-2 of the study. Out of 150 bovine 18 were bitten by lab confirmed rabid dogs/ mongooses and followed for one year. Out of 18, serum samples were taken from 15 bovine on day 14 and tested for RVNA by RFFIT and all had desired titers above 0.5 IU/ml. (Table 2 ). After appropriate wound wash and application of local antiseptics, eRIG was infiltrated locally (Figure 3 ) into all category-III wounds inflicted by suspected or lab confirmed rabid dogs/mongoose.
Those animals that were not having any visible wound were not given any eRIG Pre-vaccination of bovine, Phase-III: Pre-exposure prophylaxis was found to be effective as 0.2 ml dose of vaccine on day 0, 3, 7 and all bovine had titers higher than desired by day seven after single 0.2 ml vaccine booster at one year. We had serum samples tested for seven calves born to cows during the study period while cows were vaccinated before pregnancy and three of them had more than desired antibody levels at 3 -4 months of age. It is recommended that we vaccinate calves when they are older than 4 months and then yearly [14] [15].
Conclusion
Considering the enormous burden of rabies, we were able to demonstrate clinical effectiveness of a novel low cost protocol based on our previous experience with human rabies vaccination and local infiltration of eRIG and we called this protocol to memorise our guru as "Madhusudana-Bharti-Uppinder" protocol. Failure to achieve desired titers above 0.5 IU/ml at day 14 with IM schedule of rabies vaccination in bovine was identified as one of the reasons of observed PEP failure in bovine vaccinated by IM route in our area. Our study points towards a possibility of having short schedules of three shots ID vaccination with or without local RIG infiltration of bite wound/s as PEP and single shot ID as PrEP but that would require further studies on a large number of animals.
Recommendations
We recommend vets to follow this low cost protocol of IDRV with local eRIG [15] .
